Current
Activities and Meetings...
New Activities
Poster Awards- The ISF
will be providing awards for the best poster on Sepsis at various
International Conferences. More detail will be made available on
this site in the future.

Sepsis 2009
November 2009, Amsterdam, The
Netherlands

ISF co-session with ESICM 2009
Vienna Austria 11-14 October
Chairs: JF Dhainaut & K Reinhart
1) Combination antibiotic therapy is indicated in sever bacteremic pneumococcal
pneumonia.
Pro: John Marshall
Con: Jean Carlet
2) Vasopressin remains an important therapy for the management of septic shock
Pro: Jean-Louis Vincent
Con: Simon Finfer
3) PCT measurement should now be the standard of care in patients with suspected
infection
Pro: Konrad Reinhart
Con: Derek Angus

ISF Joint Session ECCMID 2009
Tuesday 19 May 2009, Helsinki, Finland. Beyond Antibiotics: The Biologic
Basis and Clinical Utility of Adjuvant Therapy for Severe Pneumonia.
Presentation by Dr. Landelle for best Sepsis Abstract at ECCMID
The host response in severe pneumonia: Insights from pre-clinical studies - Tom
van der Poll, Amsterdam, Netherlands
Microbial virulance factors - Steven Opal, Providence Rhode Island
Biomarkers and severity stratification - Konrad Reinhart, Jena Germany
Adjuvant therapy: Results from clinical trials - John Marshall, Toronto, Canada

ISF 8th Annual Colloquium on Divergences and Convergences
of the Septic Phenotype.
May 4-5, 2009. Pheasant Run, St Charles, IL

ISICEM 2009
ISF is endorsing the International Symposium for
Intensive Care and Emergency Medicine (ISICEM) Brussels, March 2009

Surviving Sepsis Campaign (SSC)
The ISF has collaborated with the European Society
of Intensive Care Medicine (ESICM) and the Society of Critical Care
Medicine (SCCM) on the Surviving Sepsis Campaign (SSC). The mission
of the Surviving Sepsis Campaign is to raise awareness of Sepsis and to
reduce the mortality of Sepsis.
Click here to go the SSC website.

InFACT

A number of investigator-led research consortia met in Granada Spain in November
2008 to explore ways they might better collaborate to advance investigator-led
clinical research in critical care. Over the past two decades, a number of
investigator-led research consortia have emerged around the world, and have
assumed a pre-eminent role in shaping the landscape of critical care research.
The meeting was an exploratory one to identify areas where we might
develop ongoing collaborative activities. Following the meeting a short
document will be developed that will outline the plan for InFACT and plans for a
future meeting.

This page last updated
03/16/2009
|